All In MedTech

Device Trial Radar · NCT02021617

Infusion Flow Rates and Blood Sampling

A Study Comparing Infusion Flow Rates Using the Proximal Humerus and Proximal Tibia Intraosseous Vascular Access Insertion Sites and Comparing Intraosseous and Venous Blood for Laboratory Specimen Sampling

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Nov 5, 2013

Primary completion

Nov 15, 2013

Study completion Nov 15, 2013

Sponsor

Lead sponsor
Vidacare CorporationNot on our public-company list
Sponsor type
Industry
First posted
Dec 27, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Health services research
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

* To evaluate infusion flow rates attainable when using the proximal humerus and proximal tibia IO vascular access sites. * To evaluate the intraosseous infusion physiology when using the proximal humerus and proximal tibia IO infusion sites. * To further evaluate the relationship between IO and venous blood when used for laboratory testing. * To determine the time from IO needle insertion to IO access established.

Conditions

  • Intraosseous Access
  • Infusion Rates
  • Intraosseous Blood
  • Venous Blood

Interventions

  • Intraosseous accessDevice

    The EZ-IO Intraosseous Vascular Access System (Vidacare Corporation, Shavano Park, TX, USA) has been cleared by the U.S. Food and Drug Administration, Health Canada, and the European Union for the administration of drugs and fluids anytime vascular access is difficult to obtain in emergent, urgent, or medically necessary cases. It consists of a driver-a small battery-powered drill-and a needle set designed for insertion into the IO space of the proximal tibia, distal tibia, or proximal humerus. Needles are 15 gauge and available in three lengths: 15 mm, 25 mm, and 45 mm. In this study the 45 mm EZ-IO needle set will be used for all humeral placements and the 25 mm needle set will be used for all tibial placements.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Infusion Flow RatesTime frame: 1 Day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bulverde Spring Branch EMS

    Spring Branch, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.